SI2123271T1 - Zdravilo za zdravljenje influence - Google Patents

Zdravilo za zdravljenje influence

Info

Publication number: SI2123271T1
Authority: SI; Slovenia
Prior art keywords: influenza; drug; treatment; prophylactic; therapeutic
Prior art date: 2007-03-07

Application number

SI200830440T

Other languages

English (en)

Inventor

Makoto Yamashita

Yoshihiro Kawaoka

Original Assignee

Daiichi Sankyo Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-03-07

Filing date

2008-03-03

Publication date

2012-05-31

2008-03-03 Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd

2012-05-31 Publication of SI2123271T1 publication Critical patent/SI2123271T1/sl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

SI200830440T 2007-03-07 2008-03-03 Zdravilo za zdravljenje influence SI2123271T1 (sl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2007056872		2007-03-07
EP08721158A EP2123271B1 (en)	2007-03-07	2008-03-03	Drug for treatment of influenza
PCT/JP2008/053738 WO2008108323A1 (ja)	2007-03-07	2008-03-03	インフルエンザ治療剤

Publications (1)

Publication Number	Publication Date
SI2123271T1 true SI2123271T1 (sl)	2012-05-31

Family

ID=39738201

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SI200830440T SI2123271T1 (sl)	2007-03-07	2008-03-03	Zdravilo za zdravljenje influence

Country Status (17)

Country	Link
US (2)	US20100204314A1 (sl)
EP (1)	EP2123271B1 (sl)
JP (2)	JP5286251B2 (sl)
KR (1)	KR101473028B1 (sl)
CN (1)	CN101715343B (sl)
AT (1)	ATE526960T1 (sl)
CA (1)	CA2680415A1 (sl)
CY (1)	CY1112201T1 (sl)
DK (1)	DK2123271T3 (sl)
ES (1)	ES2372996T3 (sl)
HK (1)	HK1137142A1 (sl)
HR (1)	HRP20110861T1 (sl)
PL (1)	PL2123271T3 (sl)
PT (1)	PT2123271E (sl)
SI (1)	SI2123271T1 (sl)
TW (1)	TWI424841B (sl)
WO (1)	WO2008108323A1 (sl)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7960139B2 (en)	2007-03-23	2011-06-14	Academia Sinica	Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
JP5986745B2 (ja)	2008-07-15	2016-09-06	アカデミアシニカＡｃａｄｅｍｉａＳｉｎｉｃａ	Ｐｔｆｅ様のアルミニウム・コート・ガラススライド上のグリカンアレイおよび関連する方法
US10087236B2 (en)	2009-12-02	2018-10-02	Academia Sinica	Methods for modifying human antibodies by glycan engineering
US11377485B2 (en)	2009-12-02	2022-07-05	Academia Sinica	Methods for modifying human antibodies by glycan engineering
WO2011130332A1 (en)	2010-04-12	2011-10-20	Academia Sinica	Glycan arrays for high throughput screening of viruses
CA2835489C (en)	2010-05-10	2018-03-06	Chi-Huey Wong	Zanamivir phosphonate congeners with anti-influenza activity and determining oseltamivir susceptibility of influenza viruses
CN103974945B (zh) *	2011-12-16	2016-03-09	第一三共株式会社	用于制备神经氨酸衍生物的方法
US10130714B2 (en)	2012-04-14	2018-11-20	Academia Sinica	Enhanced anti-influenza agents conjugated with anti-inflammatory activity
AU2013306098A1 (en)	2012-08-18	2015-02-12	Academia Sinica	Cell-permeable probes for identification and imaging of sialidases
US10086054B2 (en)	2013-06-26	2018-10-02	Academia Sinica	RM2 antigens and use thereof
EP3013347B1 (en)	2013-06-27	2019-12-11	Academia Sinica	Glycan conjugates and use thereof
CN105682666B (zh)	2013-09-06	2021-06-01	中央研究院	使用醣脂激活人类iNKT细胞
US10150818B2 (en)	2014-01-16	2018-12-11	Academia Sinica	Compositions and methods for treatment and detection of cancers
US9982041B2 (en)	2014-01-16	2018-05-29	Academia Sinica	Compositions and methods for treatment and detection of cancers
TWI687428B (zh)	2014-03-27	2020-03-11	中央研究院	反應性標記化合物及其用途
AU2015267045B2 (en)	2014-05-27	2021-02-25	Academia Sinica	Anti-HER2 glycoantibodies and uses thereof
EP3149161B1 (en)	2014-05-27	2021-07-28	Academia Sinica	Fucosidase from bacteroides and methods using the same
CN106573971A (zh)	2014-05-27	2017-04-19	中央研究院	抗cd20醣抗体及其用途
US10118969B2 (en)	2014-05-27	2018-11-06	Academia Sinica	Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
TWI732738B (zh)	2014-05-28	2021-07-11	中央研究院	抗TNF-α醣抗體及其用途
WO2016040369A2 (en)	2014-09-08	2016-03-17	Academia Sinica	HUMAN iNKT CELL ACTIVATION USING GLYCOLIPIDS
US9975965B2 (en)	2015-01-16	2018-05-22	Academia Sinica	Compositions and methods for treatment and detection of cancers
US10495645B2 (en)	2015-01-16	2019-12-03	Academia Sinica	Cancer markers and methods of use thereof
EP3248005B1 (en)	2015-01-24	2020-12-09	Academia Sinica	Novel glycan conjugates and methods of use thereof
TW201808978A (zh)	2016-03-08	2018-03-16	中央研究院	N-聚醣及其陣列之模組化合成方法
JP7213549B2 (ja)	2016-08-22	2023-01-27	シーエイチオーファーマインコーポレイテッド	抗体、結合性断片、および使用の方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2167682T3 (es) *	1996-07-22	2002-05-16	Sankyo Co	Derivados del acido neuraminico, su preparacion y su uso medico.
US6451766B1 (en) *	1996-07-22	2002-09-17	Sankyo Company, Limited	Neuraminic acid derivatives, their preparation and their medical use
JP3209946B2 (ja) *	1996-07-22	2001-09-17	三共株式会社	ノイラミン酸誘導体
US6340702B1 (en) *	1996-07-22	2002-01-22	Sankyo Company, Limited	Neuraminic acid derivatives, their preparation and their medical use
JP4151800B2 (ja)	1996-08-13	2008-09-17	第一三共株式会社	ノイラミン酸化合物
JP3920041B2 (ja)	2000-04-25	2007-05-30	三共株式会社	ノイラミン酸化合物の水和物及び結晶
TWI291462B (en) *	2000-04-25	2007-12-21	Daiichi Sankyo Co Ltd	Hydrate crystal of neuraminic acid compound
DE602006003600D1 (de)	2005-08-22	2008-12-24	Delphi Tech Inc	Nockenwellenversteller zur Einstellung der Phase zwischen einer Nockenwelle und einem Antriebsrad

2008
- 2008-03-03 WO PCT/JP2008/053738 patent/WO2008108323A1/ja active Application Filing
- 2008-03-03 EP EP08721158A patent/EP2123271B1/en not_active Not-in-force
- 2008-03-03 AT AT08721158T patent/ATE526960T1/de active
- 2008-03-03 PT PT08721158T patent/PT2123271E/pt unknown
- 2008-03-03 CA CA002680415A patent/CA2680415A1/en not_active Abandoned
- 2008-03-03 JP JP2009502568A patent/JP5286251B2/ja active Active
- 2008-03-03 CN CN2008800149108A patent/CN101715343B/zh active Active
- 2008-03-03 PL PL08721158T patent/PL2123271T3/pl unknown
- 2008-03-03 SI SI200830440T patent/SI2123271T1/sl unknown
- 2008-03-03 KR KR1020097018422A patent/KR101473028B1/ko active IP Right Grant
- 2008-03-03 US US12/449,909 patent/US20100204314A1/en not_active Abandoned
- 2008-03-03 ES ES08721158T patent/ES2372996T3/es active Active
- 2008-03-03 DK DK08721158.7T patent/DK2123271T3/da active
- 2008-03-07 TW TW097107984A patent/TWI424841B/zh active
2010
- 2010-04-21 HK HK10103858.3A patent/HK1137142A1/xx unknown
2011
- 2011-11-21 HR HR20110861T patent/HRP20110861T1/hr unknown
- 2011-12-30 CY CY20111101293T patent/CY1112201T1/el unknown
2013
- 2013-04-22 JP JP2013089202A patent/JP6012076B2/ja active Active
- 2013-08-27 US US14/010,784 patent/US20140018418A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CN101715343A (zh)	2010-05-26
KR101473028B1 (ko)	2014-12-15
PL2123271T3 (pl)	2012-03-30
CY1112201T1 (el)	2015-12-09
JP5286251B2 (ja)	2013-09-11
ES2372996T3 (es)	2012-01-30
WO2008108323A1 (ja)	2008-09-12
JPWO2008108323A1 (ja)	2010-06-17
TW200848018A (en)	2008-12-16
HK1137142A1 (en)	2010-07-23
US20100204314A1 (en)	2010-08-12
PT2123271E (pt)	2011-12-20
TWI424841B (zh)	2014-02-01
HRP20110861T1 (hr)	2011-12-31
EP2123271A1 (en)	2009-11-25
CN101715343B (zh)	2012-09-26
US20140018418A1 (en)	2014-01-16
CA2680415A1 (en)	2008-09-12
EP2123271B1 (en)	2011-10-05
JP2013139483A (ja)	2013-07-18
ATE526960T1 (de)	2011-10-15
DK2123271T3 (da)	2012-01-23
JP6012076B2 (ja)	2016-10-25
KR20090129414A (ko)	2009-12-16
EP2123271A4 (en)	2010-03-17

Publication	Publication Date	Title
HK1137142A1 (en)	2010-07-23	Drug for treatment of influenza
HK1139381A1 (en)	2010-09-17	Bicyclic -amino acid derivative
TW200728307A (en)	2007-08-01	Novel spirochromanone derivatives
SG171617A1 (en)	2011-06-29	Therapeutic compounds
TW200621737A (en)	2006-07-01	2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
MX2010004232A (es)	2010-09-30	Compuesto de indolina de pirimidilo.
WO2007084728A3 (en)	2008-01-17	2-imino-benzimidazoles
MX2009012125A (es)	2010-02-18	Compuestos terapeuticos.
NO20052074L (no)	2005-06-01	Substituerte benzoksazinoner og anvendelser derav.
HK1159614A1 (en)	2012-08-03	Caspase inhibitors and uses thereof
DK1694318T3 (da)	2007-06-25	(S)-2-N-propylamino-5-hydroxytetralin som D3-agonistisk terapeutikum
IL183373A0 (en)	2007-09-20	3-[2-(3-acylamino-2-oxo-2h-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof
MX2011011776A (es)	2012-08-03	Nuevos profarmacos de triptolite.
IL172290A0 (en)	2006-04-10	Use of 2-amino-1-3-propanediol derivatives for the manufacture of a medicament for the treatment of various types of pain
WO2009051223A1 (ja)	2009-04-23	白内障処置のための医薬組成物
MY138466A (en)	2009-06-30	Aminoalkoxyndoles as 5-ht6-receptor ligands for the treatment of cns-disorders
ZA201007603B (en)	2012-08-29	Therapeutic compounds
MX2011012068A (es)	2012-06-08	Nucleosidos 2'-fluoro arabino y su utilizaicon.
MX2010001304A (es)	2010-09-07	Compuestos terapeuticos.
MY139228A (en)	2009-08-28	Imidazolinylmethyl aralkylsulfonamides
TW200606148A (en)	2006-02-16	Indolylalkylamine metabolites as 5-hydroxytryptamine-6 ligands
BRPI0514020A (pt)	2008-05-27	oxindóis oxazolidinonas como agentes antibacterianos
TN2012000093A1 (en)	2013-09-19	Therapeutic agent for anxiety disorders
UA88766C2 (ru)	2009-11-25	Производные хинолина для лечения латентного туберкулеза
MX2010004405A (es)	2010-05-03	Derivados de pirrolo [1,2-c] imidazol para utilizarse en la profilaxis o tratamiento de cancer que es refractario a terapias cancerigenas conocidas.